Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 24, 2001
[Positron emission tomography in thoracic radiography]
F Vaylet, H Foehrenbach, J Guigay, et al.
Revue De Pneumologie Clinique
|
February 9, 2005
[The risk of thromboembolism in airline passengers]
J Margery, A Bonnichon, K Hardy, et al.
Oral Oncology
|
March 29, 2017
Long-term response in patient with recurrent oropharyngeal carcinoma treated with cetuximab, docetaxel and cisplatin (TPEx) as first-line treatment followed by cetuximab maintenance
J Guigay, C Even, L Mayache-Badis, et al.
Revue De Pneumologie Clinique
|
August 5, 2004
[An unusual cause of acute respiratory distress: obstructive bronchial aspergillosis]
J Margery, J-P Perez, F Vaylet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
March 10, 2001
[A revolution in pneumology: positron-emission tomography]
F Vaylet, O de Dreuille, P Maszelin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 23, 2017
[Reirradiation of head and neck cancers]
J Doyen, D Lam Cham Kee, L Krebs, et al.
ESMO Open
|
November 7, 2025
MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer
E Borcoman, A Hervieu, C Cropet, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 5, 2014
Squamous cell carcinoma of the larynx with subglottic extension: is larynx preservation possible?
A Levy, P Blanchard, S Temam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2012
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)
S Schmitz, M-C Kaminsky-Forrett, S Henry, et al.
Bulletin Du Cancer
|
September 12, 2009
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]
E Bardet, J Bourhis, L Cals, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 24, 2001
[Positron emission tomography in thoracic radiography]
F Vaylet, H Foehrenbach, J Guigay, et al.
Revue De Pneumologie Clinique
|
February 9, 2005
[The risk of thromboembolism in airline passengers]
J Margery, A Bonnichon, K Hardy, et al.
Oral Oncology
|
March 29, 2017
Long-term response in patient with recurrent oropharyngeal carcinoma treated with cetuximab, docetaxel and cisplatin (TPEx) as first-line treatment followed by cetuximab maintenance
J Guigay, C Even, L Mayache-Badis, et al.
Revue De Pneumologie Clinique
|
August 5, 2004
[An unusual cause of acute respiratory distress: obstructive bronchial aspergillosis]
J Margery, J-P Perez, F Vaylet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
March 10, 2001
[A revolution in pneumology: positron-emission tomography]
F Vaylet, O de Dreuille, P Maszelin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 23, 2017
[Reirradiation of head and neck cancers]
J Doyen, D Lam Cham Kee, L Krebs, et al.
ESMO Open
|
November 7, 2025
MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer
E Borcoman, A Hervieu, C Cropet, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 5, 2014
Squamous cell carcinoma of the larynx with subglottic extension: is larynx preservation possible?
A Levy, P Blanchard, S Temam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2012
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)
S Schmitz, M-C Kaminsky-Forrett, S Henry, et al.
Bulletin Du Cancer
|
September 12, 2009
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]
E Bardet, J Bourhis, L Cals, et al.
Page
of 7